Schedule an Amyloid PET/CT scan
Amyloid PET/CT: The first step in qualifying for LEQEMBI, a new treatment for Alzheimer's Disease
Progresive, quality care
Shields Health has been at the leading-edge of Alzheimer's Disease research and testing for years. Our experienced clinical team has led research studies evaluating the effectiveness of PET/CT studies related to amyloid plaque and their experience ensures the very BEST care.
Latest, cutting edge technology
Cutting-edge PET/CT technology at every location ensures precise imaging and accurate diagnosis. Most of our systems are less than five years old!
Largest network
With 15 locations offering amyloid PET/CT imaging, our experience with this new process runs deep. Shields PET/CT is here for you.
Frequently Asked Questions
We are now accepting:
- Anthem ME
- BCBSMA Commercial
- BCBSMA MCR Adv
- BMC/Wellsense
- Cigna
- Commonwealth Care Alliance
- Community Health Options (ME)
- Fallon Direct & Comm Care
- Fallon Medicare
- Fallon Select PPO
- HPHC
- Humana
- Medicare
- MGBHP
- Senior Whole Health
- Today's Options (ME)
- Tufts Commercial
- Tufts Mediare Preferred
- Tufts Public (MCR)
- Unicare GIC
- US Family
Shields is actively working with insurance companies and we anticipate that this process will advance quickly to include more coverage. For the most up-to-date insurance information, reference this list or contact our PET/CT customer care team at 1-800-258-4674
Only 10-20 minutes.
No, currently we are not able to accept out-of-pocket payment for this scan type. If you have any questions, please contact our PET/CT customer care team at 1.800.258.4674
One. But once on Leqembi, it’s likely that the patient would
need to be monitored for ARIA with MRI.
There is no single diagnostic test that can determine if a person has Alzheimer’s Disease disease. Physicians use a variety of approaches and tools to help make a diagnosis. To diagnose Alzheimer’s Disease, physicians may use medical history, mental status tests, physical and neurological exams, diagnostic tests and brain imaging. However, for a patient to be eligible to receive Leqembi, a physician is required to confirm the presence of the disease’s key biomarker beta-amyloid plaques. There are ultimately only two reliable ways to do this: a lumbar puncture
and a PET/CT scan.
PET/CT is the only noninvasive option to confirm the
presence of beta-amyloid plaques in the brain. Many patients will refuse or are unable to undergo a lumbar puncture, and those with ambiguous symptoms need an amyloid PET/CT scan to receive a diagnosis.
Lumbar punctures survey the fluid bathing the brain and spinal cord, called the cerebrospinal fluid (CSF), looks for fragments of brain plaques. PET/CT scans involve injecting a safe radioactive marker into the bloodstream that binds to amyloid plaques in the brain. When the brain is scanned, these plaques “light up.” If someone receives a lumbar puncture and a PET/CT scan, it is likely that the results will agree with each other. However, sometimes
a PET/CT scan provides extra information that could correct a faulty diagnosis.
Amyloid PET/CT Imaging
Amyloid PET/CT scan now offered across our network
2033 Main Street, Athol, MA 01331, United States
211 Park Street, Attleboro, MA 02703, United States
275 Nichols Rd, Fitchburg, MA 01420, USA
100 South St, Southbridge, MA 01550, USA
800 Washington St, Boston, MA 02111, USA
114 Sanford Road, Wells, ME, USA
Cooley Dickinson Hospital, Locust Street, Northampton, MA, USA
165 Tor Ct, Pittsfield, MA, USA
2 Jan Sebastian Drive, Sandwich, MA, USA
525 Long Pond Road, Harwich, MA, USA
680 Centre Street, Brockton, MA, USA
55 Fogg Road, Weymouth, MA, USA
133 Old Road to Nine Acre Corner Concord, MA 01742
12 High Street, Lewiston, ME 04240, USA
214 Shrewsbury St, Worcester, MA, USA
14 Cochituate Road, Framingham, MA, USA
80 Wason Ave, Springfield, Massachusetts, USA
25 Highland Avenue, Newburyport, MA, USA